Research News
View articles by month and year
1–6 of 6 articles
-
Aspirin Seems to Improve Prognosis
Research suggests that premenopausal women who took two or more aspirin each week in the years after a diagnosis of early-stage breast cancer have a better prognosis than women who don't take aspirin.
-
No Link Between Anti-Inflammatory Pain Medicines and Lower Risk in Younger Women
Results from the Nurses' Health Study show that regularly taking aspirin, other NSAIDs, or acetaminophen doesn't reduce breast cancer risk in premenopausal women.
-
Daily Aspirin May Reduce Risk of Estrogen-Receptor-Positive Breast Cancer
Taking aspirin every day may offer some protection against estrogen-receptor-positive breast cancer.
-
Link Between Risk, Anti-Inflammatory Medicines Unclear
A review of research results suggests an association between nonsteroidal anti-inflammatory (NSAID) medicines and breast cancer risk.
-
Ibuprofen, Aspirin May Reduce Risk
Regularly taking nonsteroidal anti-inflammatory medicines, such as aspirin and ibuprofen, seems to be associated with a lower risk of breast cancer, but the results are still inconclusive.
-
Daily Adult-Strength Aspirin May Lower Risk
Taking adult-strength aspirin every day may reduce cancer risk.
1–6 of 6 articles
